TRCT
GNVC

Tower Research Capital (TRC)’s GenVec, Inc. GNVC Stock Holding History

Tower Research Capital (TRC)’s Portfolio GNVC Stock Details GNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-730
Closed -$4K – 4095
2017
Q1 		$4K Buy
+730
New +$4.56K ﹤0.01% 2427
2016
Q1 		– Sell
-113
Closed -$2K – 5861
2015
Q4 		$2K Buy
+113
New +$2.16K ﹤0.01% 3995
2015
Q3 		– Sell
-72
Closed -$1K – 5748
2015
Q2 		$1K Sell
72
-81
-53% -$1.98K ﹤0.01% 4298
2015
Q1 		$5K Buy
153
+135
+750% +$4.43K ﹤0.01% 3358
2014
Q4 		$0 Buy
+18
New +$348 ﹤0.01% 5627
2014
Q3 		– Sell
-40
Closed -$1K – 5534
2014
Q2 		$1K Buy
40
+30
+300% +$736 ﹤0.01% 3940
2014
Q1 		$0 Sell
10
-1,290
-99% -$42.1K ﹤0.01% 5632
2013
Q4 		$30K Buy
+1,300
New +$22.3K 0.01% 1914

Tower Research Capital (TRC)'s GNVC Position: Q2 2017 in Review

Tower Research Capital (TRC) sold out of GenVec, Inc. (GNVC) in Q2 2017, closing a stake of 730 shares — an estimated $4K sold.

Tower Research Capital (TRC) first reported a position in GNVC in Q4 2013 and held it in 8 quarters. The position peaked at $30K in Q4 2013. 0 funds tracked by Wall St. Rank hold GNVC as of Q2 2017.

  • Tower Research Capital (TRC) reported no remaining GenVec, Inc. position as of Q2 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 730 GenVec, Inc. shares in Q2 2017, an estimated $4K.
  • Tower Research Capital (TRC) first reported a position in GenVec, Inc. in Q4 2013 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s GenVec, Inc. position peaked at $30K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held GenVec, Inc. as of Q2 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.